{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:32:19Z","timestamp":1789014739276,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Bari Aldo Moro"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We identified STAT1 gain of function (GOF) in a 32-year-old female with pallor, weakness, cough, and dyspnea admitted to our Division of Medicine. She had severe oral ulcers (OU), type 1 diabetes (T1DM), and pancytopenia. Bone marrow (BM) biopsy showed the absence of erythroid precursors. Peripheral blood parameters such as neutrophils\u2009&lt;\u2009500\/mL, reticulocytes\u2009&lt;\u20092%, and BM hypo-cellularity allowed to diagnose severe aplastic anemia. A heterozygous variant (p.520T&gt;C, p.Cys174Arg) of STAT1 was uncovered. Thus, p.Cys174Arg mutation was investigated as potentially responsible for the patient's inborn immunity error and aplastic anemia. Although STAT1 GOF is rare, aplastic anemia is a more common condition; therefore, we explored STAT1 functional role in the pathobiology of BM failure. Interestingly, in a cohort of six patients with idiopathic aplastic anemia, enhanced phospho-STAT1 levels were observed on BM immunostaining. Next, the most remarkable features associated with STAT1 signaling dysregulation were examined: in both pure red cell aplasia and aplastic anemia, CD8<jats:sup>+<\/jats:sup>\u2009T cell genetic variants and mutations display enhanced signaling activities related to the JAK-STAT pathway. Inborn errors of immunity may represent a paradigmatic condition to unravel crucial pathobiological mechanisms shared by common pathological conditions. Findings from our case-based approach and the phenotype correspondence to idiopathic aplastic anemia cases prompt further statistically powered prospective studies aiming to elucidate the exact role and theragnostic window for JAK\/STAT targeting in this clinical context. Nonetheless, we demonstrate how a comprehensive study of patients with primary immunodeficiencies can lead to pathophysiologic insights and potential therapeutic approaches within a broader spectrum of aplastic anemia cases.<\/jats:p>","DOI":"10.1007\/s10238-023-01017-0","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T16:02:56Z","timestamp":1677254576000},"page":"2687-2694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure"],"prefix":"10.1007","volume":"23","author":[{"given":"Antonio Giovanni","family":"Solimando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Desantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Marasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Pappagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Montagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ingravallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Cicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Di Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Tabares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Beilhack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Dammacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"1017_CR1","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra1413485","volume":"379","author":"NS Young","year":"2018","unstructured":"Young NS. Aplastic anemia. N Engl J Med. 2018;379:1643\u201356.","journal-title":"N Engl J Med"},{"issue":"77","key":"1017_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bcmd.2019.03.009","volume":"203","author":"S Zhao","year":"2019","unstructured":"Zhao S, Zhang Y, Huang G, et al. Increased CD8+CD27+perforin+ T cells and decreased CD8+CD70+ T cells may be immune biomarkers for aplastic anemia severity. Blood Cells Mol Dis. 2019;203(77):34\u201342.","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"1017_CR3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/cei.12642","volume":"181","author":"DC Ifrim","year":"2015","unstructured":"Ifrim DC, Quintin J, Meerstein-Kessel L, et al. Defective trained immunity in patients with STAT-1-dependent chronic mucocutaneaous candidiasis. Clin Exp Immunol. 2015;181(3):434\u201340. https:\/\/doi.org\/10.1111\/cei.12642.","journal-title":"Clin Exp Immunol"},{"key":"1017_CR4","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1084\/jem.20110958","volume":"209\u2013208","author":"L Liu","year":"2011","unstructured":"Liu L, Okada S, Kong X-F, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;209\u2013208:1635\u201348.","journal-title":"J Exp Med"},{"issue":"1","key":"1017_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10875-018-0575-y","volume":"39","author":"A Kiykim","year":"2019","unstructured":"Kiykim A, Charbonnier LM, Akcay A, et al. Hematopoietic stem cell transplantation in patients with heterozygous STAT1 gain-of-function mutation. J Clin Immunol. 2019;39(1):37\u201344. https:\/\/doi.org\/10.1007\/s10875-018-0575-y.","journal-title":"J Clin Immunol"},{"issue":"8","key":"1017_CR6","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1111\/j.1538-7836.2012.04757.x","volume":"10","author":"X Feng","year":"2012","unstructured":"Feng X, Scheinberg P, Samsel L, et al. Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura. J Thromb Haemost. 2012;10(8):1616\u201323. https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04757.x.","journal-title":"J Thromb Haemost"},{"key":"1017_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cyto.2018.03.041","volume":"118","author":"HM Hammar\u00e9n","year":"2019","unstructured":"Hammar\u00e9n HM, Virtanen AT, Raivola J, Silvennoinen O. The regulation of JAKs in cytokine signaling and its breakdown in disease. Cytokine. 2019;118:48\u201363. https:\/\/doi.org\/10.1016\/j.cyto.2018.03.041.","journal-title":"Cytokine"},{"key":"1017_CR8","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","volume":"127","author":"J Toubiana","year":"2016","unstructured":"Toubiana J, Okada S, Hiller J, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127:3154\u201364.","journal-title":"Blood"},{"key":"1017_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMoa1100102","volume":"365","author":"FL van de Veerdonk","year":"2011","unstructured":"van de Veerdonk FL, Plantinga TS, Hoischen A, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med. 2011;365:54\u201361.","journal-title":"N Engl J Med"},{"issue":"4","key":"1017_CR10","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s10875-020-00943-y","volume":"41","author":"B Kayaoglu","year":"2021","unstructured":"Kayaoglu B, Kasap N, Yilmaz NS, et al. Stepwise reversal of immune dysregulation due to STAT1 gain-of-function mutation following ruxolitinib bridge therapy and transplantation. J Clin Immunol. 2021;41(4):769\u201379. https:\/\/doi.org\/10.1007\/s10875-020-00943-y.","journal-title":"J Clin Immunol"},{"issue":"7","key":"1017_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10875-016-0312-3","volume":"36","author":"S Baris","year":"2016","unstructured":"Baris S, Alroqi F, Kiykim A, et al. Severe early-onset combined immunodeficiency due to heterozygous gain-of-function mutations in STAT1. J Clin Immunol. 2016;36(7):641\u20138. https:\/\/doi.org\/10.1007\/s10875-016-0312-3.","journal-title":"J Clin Immunol"},{"key":"1017_CR12","doi-asserted-by":"publisher","first-page":"9394","DOI":"10.1073\/pnas.1511711112","volume":"112","author":"C-K Wan","year":"2015","unstructured":"Wan C-K, Andraski AB, Spolski R, et al. Opposing roles of STAT1 and STAT3 in IL-21 function in CD4 + T cells. Proc Natl Acad Sci USA. 2015;112:9394\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1017_CR13","doi-asserted-by":"publisher","DOI":"10.4161\/jkst.27521","volume":"2","author":"K Fink","year":"2013","unstructured":"Fink K, Grandvaux N. STAT2 and IRF9: beyond ISGF3. JAK-STAT. 2013;2: e27521.","journal-title":"JAK-STAT"},{"key":"1017_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.biochi.2010.02.009","volume":"92","author":"I Najjar","year":"2010","unstructured":"Najjar I, Fagard R. STAT1 and pathogens, not a friendly relationship. Biochimie. 2010;92:425\u201323244.","journal-title":"Biochimie"},{"key":"1017_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1159\/000324176","volume":"2343","author":"JD Brandstadter","year":"2011","unstructured":"Brandstadter JD, Yang Y. Natural killer cell responses to viral infection. J Innate Immun. 2011;2343:274\u20139.","journal-title":"J Innate Immun"},{"key":"1017_CR16","doi-asserted-by":"publisher","first-page":"2372383","DOI":"10.1084\/jem.20070401","volume":"204","author":"T Miyagi","year":"2007","unstructured":"Miyagi T, Gil MP, Wang X, Louten J, Chu W-M, Biron CA. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells. J Exp Med. 2007;204:2372383\u201396.","journal-title":"J Exp Med"},{"key":"1017_CR17","doi-asserted-by":"publisher","first-page":"eaay5731","DOI":"10.1126\/science.aay5731","volume":"371","author":"TJ Break","year":"2021","unstructured":"Break TJ, Oikonomou V, Dutzan N, et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science. 2021;371:eaay5731.","journal-title":"Science"},{"key":"1017_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.thj.6200340","volume":"5","author":"JP Welsh","year":"2004","unstructured":"Welsh JP, Rutherford TR, Flynn J, Foukaneli T, Gordon-Smith EC, Gibson FM. In vitro effects of interferon-\u03b3 and tumor necrosis factor-\u03b1 on CD34+ bone marrow progenitor cells from aplastic anemia patients and normal donors. Hematol J. 2004;5:39\u201346.","journal-title":"Hematol J"},{"key":"1017_CR19","doi-asserted-by":"publisher","unstructured":"Bousfiha A, Moundir A, Tangye SG, et al. The 2022 update of iuis phenotypical classification for human inborn errors of immunity [published online ahead of print, 2022 Oct 6]. J Clin Immunol. 2022. https:\/\/doi.org\/10.1007\/s10875-022-01352-z","DOI":"10.1007\/s10875-022-01352-z"},{"issue":"1","key":"1017_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.medj.2021.12.003","volume":"3","author":"JM Rosenberg","year":"2022","unstructured":"Rosenberg JM, Peters JM, Hughes T, et al. JAK inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a common feature of aplastic anemia. Med (N Y). 2022;3(1):42-57.e5. https:\/\/doi.org\/10.1016\/j.medj.2021.12.003.","journal-title":"Med (N Y)"},{"key":"1017_CR21","doi-asserted-by":"publisher","first-page":"928213","DOI":"10.3389\/fimmu.2022.928213","volume":"13","author":"Y Xie","year":"2022","unstructured":"Xie Y, Shao F, Lei J, Huang N, Fan Z, Yu H. Case report: A STAT1 gain-of-function mutation causes a syndrome of combined immunodeficiency, autoimmunity and pure red cell aplasia. Front Immun. 2022;13:928213.","journal-title":"Front Immun"},{"issue":"19","key":"1017_CR22","doi-asserted-by":"publisher","first-page":"11765","DOI":"10.3390\/ijms231911765","volume":"23","author":"AG Solimando","year":"2022","unstructured":"Solimando AG, Palumbo C, Pragnell MV, Bittrich M, Argentiero A, Krebs M. Aplastic anemia as a roadmap for bone marrow failure: an overview and a clinical workflow. Int J Mol Sci. 2022;23(19):11765.","journal-title":"Int J Mol Sci"},{"key":"1017_CR23","doi-asserted-by":"crossref","unstructured":"Solimando AG, Vacca A, Ribatti D. Inborn error of immunity: a journey through novel genes and clinical presentation. J Encycl Infect Immun 2022;798\u2013818.","DOI":"10.1016\/B978-0-12-818731-9.00124-5"},{"key":"1017_CR24","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/s41375-021-01231-3","volume":"35","author":"S Lundgren","year":"2021","unstructured":"Lundgren S, Ker\u00e4nen MAI, Kankainen M, et al. Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia. Leukemia. 2021;35:1365\u201379.","journal-title":"Leukemia"},{"key":"1017_CR25","first-page":"9","volume":"8","author":"AG Solimando","year":"2022","unstructured":"Solimando AG, Melaccio A, Vacca A, Ria R. The bone marrow niche landscape: a journey through aging, extrinsic and intrinsic stressors in the haemopoietic milieu. J Cancer Metastasis Treat. 2022;8:9.","journal-title":"J Cancer Metastasis Treat"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01017-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01017-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01017-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T17:17:32Z","timestamp":1696094252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01017-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["1017"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01017-0","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"assertion":[{"value":"28 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"It is stated that the authors have no commercial or financial arrangements that could construe their research as having a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}